Nuveen Asset Management LLC Has $3.11 Million Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Nuveen Asset Management LLC grew its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 34.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 422,475 shares of the company’s stock after buying an additional 107,695 shares during the period. Nuveen Asset Management LLC owned 0.11% of LifeStance Health Group worth $3,114,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in LFST. Blue Trust Inc. boosted its stake in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the period. Ameriprise Financial Inc. bought a new position in shares of LifeStance Health Group during the 4th quarter worth approximately $87,000. Cibc World Markets Corp bought a new position in shares of LifeStance Health Group during the 4th quarter worth approximately $96,000. Forum Financial Management LP bought a new position in shares of LifeStance Health Group during the 4th quarter worth approximately $110,000. Finally, Handelsbanken Fonder AB bought a new position in shares of LifeStance Health Group during the 4th quarter worth approximately $128,000. 85.50% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This trade represents a 5.25% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.20% of the company’s stock.

LifeStance Health Group Price Performance

LifeStance Health Group stock opened at $5.95 on Monday. The stock’s fifty day moving average price is $6.32 and its two-hundred day moving average price is $7.12. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $8.61. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market cap of $2.31 billion, a PE ratio of -22.88 and a beta of 1.30.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on LFST shares. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. UBS Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $8.50 price target for the company in a report on Tuesday, May 27th. Canaccord Genuity Group started coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a “buy” rating and a $8.00 price target for the company. Finally, KeyCorp started coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price objective on the stock. One research analyst has rated the stock with a sell rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $8.50.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.